Alcohol Withdrawal Management

First-Line Pharmacological Treatment

Long-acting benzodiazepines, such as diazepam and chlordiazepoxide, are the first choice for alcohol withdrawal due to their efficacy in reducing withdrawal symptoms and preventing seizures and delirium tremens, as recommended by the American Association for the Study of Liver Diseases 1, 3
Short and intermediate-acting benzodiazepines, such as lorazepam and oxazepam, are safer in elderly patients and those with hepatic dysfunction, according to the American College of Gastroenterology 1, 4

Validated instruments like AUDIT-3, AUDIT-C, or ASSIST should be used for screening hazardous and harmful alcohol use, as suggested by the World Health Organization 3
The CIWA-Ar scale should guide treatment intensity, with scores >8 indicating moderate withdrawal and ≥15 indicating severe withdrawal requiring more aggressive treatment, as recommended by the American Society of Addiction Medicine 2, 4

Thiamine (100-300 mg/day) must be administered to all patients with alcohol withdrawal to prevent Wernicke encephalopathy, as recommended by the National Institute on Alcohol Abuse and Alcoholism 2, 4, 5
Parenteral thiamine should be given to patients at high risk (malnourished, severe withdrawal) or with suspected Wernicke's encephalopathy, according to the European Federation of Neurological Societies 3

Patients at risk of severe withdrawal, those with concurrent serious physical or psychiatric disorders, or those lacking adequate support should preferably be managed in an inpatient setting, as recommended by the American Medical Association 3

For alcohol withdrawal seizures, benzodiazepines remain the treatment of choice rather than anticonvulsants, according to the American Academy of Neurology 3, 4

After acute withdrawal management, medications to prevent relapse should be considered: acamprosate, disulfiram, or naltrexone, as recommended by the American Psychiatric Association 3
Disulfiram should be avoided in patients with severe alcoholic liver disease due to potential hepatotoxicity, as warned by the American Association for the Study of Liver Diseases 1, 2
Naltrexone should be used with caution in patients with liver disease, according to the National Institute on Alcohol Abuse and Alcoholism 1

Psychosocial support should be routinely offered to alcohol-dependent patients, as recommended by the Substance Abuse and Mental Health Services Administration 3
Structured psychological interventions, such as motivational techniques, should be considered when available, according to the National Institute on Alcohol Abuse and Alcoholism 3

Benzodiazepine treatment should not exceed 10-14 days to avoid the risk of dependence, as warned by the American Society of Addiction Medicine 2, 4
Antipsychotic medications should not be used as stand-alone medications for alcohol withdrawal management, as recommended by the American Psychiatric Association 3
Missing Wernicke encephalopathy can lead to irreversible neurological damage if not treated promptly with thiamine, as emphasized by the European Federation of Neurological Societies 5